Funded by Spencer Dayman Meningitis Research, Scientists at the University of Bristol will soon begin a ground breaking research project to provide evidence to develop a diagnostic kit which will give an accurate and sensitive diagnosis in five minutes to combat meningitis, sepsis and other infectious diseases.
“Infections of the blood (sepsis) and the region surrounding the brain (meningitis) can progress and become life threatening very rapidly. It is very difficult to detect in its early stages. Therefore, rapid identification is paramount in order to save lives” said Charity founder Dr Steve Dayman “ in order to inform the most important type of treatment, it is essential to identify if the infection is caused by a virus or bacteria.
At present identification can be slow, inaccurate and often needs expensive equipment and the longer the delay in inappropriate treatment the worse things will be for the patient” said Professor Dr Darryl Hill who is leading the research project “Ideally the technology would be useable in multiple settings including doctors’ surgery’s, health centres, hospitals and by paramedics” This 12-month trailblazing research project. Entitled: Gold bionanoconjugates for the rapid detection of bacteria causing sepsis and meningitis will be undertaken at the Spencer Dayman Meningitis Laboratories, University of Bristol, at a cost of £49,400,30 starting on 1st September this year. The lead investigators are: Professor Dr Darryl Hill & Senior Lecturer Dr Sean Davis.
Senior Lecturer Dr Sean Davis
Dr Sean Davis said “We really value the essential financial support from Spencer Dayman Meningitis Research. This grant will help us to continue our scientific preventative research into meningitis and other associated diseases”
Thanks to the wonderful support of families who have been affected by meningitis, sepsis and other associated diseases, the general public and grant giving intuitions. In just over 12 months since the inception of Spencer Dayman Meningitis Research we have committed over £112,000.00 towards scientific research into the prevention of meningitis, sepsis and other associated diseases.
